Stryker (SYK) Cash & Equivalents (2009 - 2026)

Stryker (SYK) has reported Cash & Equivalents for 18 consecutive years, with $3.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 42.78% year-over-year to $3.4 billion in Q2 2026; TTM through Jun 2026 was $3.4 billion, a 42.78% increase from a year earlier, with the FY2025 full-year figure at $4.0 billion, up 9.83% from the prior year.
• Cash & Equivalents was $3.4 billion for Q2 2026 at Stryker, up from $2.9 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $4.0 billion in Q4 2025 and troughed at $1.0 billion in Q2 2022.
• A 5-year average of $2.4 billion and a median of $2.3 billion in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 53.41% in 2022 and jumped 106.99% in 2024, its largest moves.
• Over 5 years, Cash & Equivalents stood at $1.8 billion in 2022, then surged by 61.12% to $3.0 billion in 2023, then advanced by 22.92% to $3.7 billion in 2024, then grew by 9.83% to $4.0 billion in 2025, then retreated by 15.46% to $3.4 billion in 2026.
• The last three Cash & Equivalents figures came in at $3.4 billion (Q2 2026), $2.9 billion (Q1 2026), and $4.0 billion (Q4 2025), per Business Quant data.